Acetylcholine (ACh) induces hyperpolarization and dilation in a variety of blood vessels, including the cochlear spiral modiolar artery (SMA) via the endothelium-derived hyperpolarization factor (EDHF). We demonstrated previously that the ACh-induced hyperpolarization in the SMA originated in the endothelial cells (ECs) by activating a Ca 2ϩ -activated K ϩ channel (K Ca ); the hyperpolarization in smooth muscle cells was mainly an electrotonic spread via gap junction coupling. In the present study, using intracellular recording, immunohistology, and vascular diameter tracking techniques on in vitro SMA preparations, we found that 1) ACh-induced hyperpolarization was suppressed by intermediate-conductance K Ca (IK) blockers clotrimazole (IC 50 ϭ 116 nM) and nitrendipine and by the calmodulin antagonist trifluoperazine, but it was not suppressed by the bigconductance K Ca blocker iberiotoxin. The immunoreactivity to anti-SK4/IK1 antibody was localized mainly in ECs.2) The three dihydropyridines-nifedipine, nitrendipine, and nimodipine-all concentration-dependently inhibited the ACh-induced hyperpolarization, with an IC 50 value of 455, 34, and 3.2 nM, respectively. 3) Among other L-type Ca 2ϩ channel (I L ) blockers, 10 M verapamil exerted a 20% inhibition on ACh-induced hyperpolarization, whereas diltiazem and the metal ion Ca 2ϩ channel blockers Cd 2ϩ and Ni 2ϩ had no effect. 4) Nitrendipine and charybdotoxin abolished ACh-induced dilation in the SMA. We conclude that ACh-induced hyperpolarization in the SMA is generated mainly by activation of the IK in the ECs, and dihydropyridines suppress the EDHF-mediated hyperpolarization by blocking the IK channel, not the I L channel. The clinical relevance of this dihydropyridine action is discussed.Several vasoactive agents, such as acetylcholine (ACh), substance P, and bradykinin, cause robust hyperpolarization and vasodilation when the endothelium is intact. The hyperpolarization and vasodilation have been attributed to endothelium-derived hyperpolarization factor (EDHF) or endothelium-derived relaxation factor (Faraci and Heistad, 1998;Busse et al., 2002). The EDHF is an important mechanism regulating blood flow to organs and tissues and is implicated in vascular pathology, such as ischemia, hypertension, atherosclerosis, diabetic and aging vascular malfunction (Faraci and Heistad, 1998), and coronary vascular spasms (Konidala and Gutterman, 2004).The EDHF seems to be a variable combination of gap junction coupling, endothelial release of K ϩ , NO, epoxyeicosatrienoic acids, and prostanoid in various vascular beds and in different animal species (Busse et al., 2002). We reported recently that ACh induced hyperpolarization and dilation in the cochlear spiral modiolar artery (SMA) via the EDHF (Jiang et al., 2005) and found that ACh-induced EDHF in the SMA was a complex. The induced hyperpolarization originated in the endothelial cell (EC) by activating Ca 2ϩ -acti-